Literature DB >> 19789902

Effects of weight loss on lipid transfer proteins in morbidly obese women.

Markus W Laimer1, Julia Engl, Alexander Tschoner, Susanne Kaser, Andreas Ritsch, Tobias Tatarczyk, Markus Rauchenzauner, Helmut Weiss, Franz Aigner, Josef R Patsch, Christoph F Ebenbichler.   

Abstract

Obesity is associated with lipid abnormalities leading to an increased morbidity and mortality from atherosclerotic disease. Lipid transfer proteins such as Cholesteryl Ester Transfer Protein (CETP) and Phospholipid Transfer Protein (PLTP), and lipases such as lipoprotein lipase (LPL) and hepatic lipase (HL) are involved in the pathogenesis of the obesity associated proatherogenic dyslipidemia. Nineteen severely obese female subjects undergoing laparosopic gastric banding participated in this prospective study. Subjects were examined with respect to body composition, lipid profile, CETP, PLTP, LPL and HL before and 1 year after surgical treatment. Mean weight loss was 22.2 kg, mainly due to losses in the fat depots. Triglycerides decreased and HDL(2)-C increased significantly. In respect to transfer proteins mean CETP mass decreased from 1.82 to 1.71 microg mL(-1) (P = 0.043) and mean PLTP activity was reduced from 7.15 to 6.12 micromol mL(-1) h(-1) (P = 0.002), in parallel. In addition, both mean LPL activity and mean HL activity tended to decrease from 297 to 248 nmol mL(-1) h(-1) for LPL (P = 0.139) and from 371 to 319 nmol mL(-1) h(-1) for HL (P = 0.170), respectively. We conclude that weight loss induced by bariatric surgery is associated with the amelioration of the obesity-associated dyslipidemic state. This improvement may be attributable to decreased mass and action of the adipocyte tissue derived lipid transfer proteins CETP and PLTP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19789902     DOI: 10.1007/s11745-009-3349-8

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  36 in total

1.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men.

Authors:  J Q Purnell; S E Kahn; J J Albers; D N Nevin; J D Brunzell; R S Schwartz
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

4.  Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study.

Authors:  S Lamon-Fava; P W Wilson; E J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-12       Impact factor: 8.311

5.  Gastric Banding for Morbid Obesity: Initial Experience with a New Adjustable Band.

Authors: 
Journal:  Obes Surg       Date:  1993-11       Impact factor: 4.129

6.  Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism.

Authors:  R P Dullaart; W J Sluiter; L D Dikkeschei; K Hoogenberg; A Van Tol
Journal:  Eur J Clin Invest       Date:  1994-03       Impact factor: 4.686

Review 7.  Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism.

Authors:  Karina Preiss-Landl; Robert Zimmermann; Günter Hämmerle; Rudolf Zechner
Journal:  Curr Opin Lipidol       Date:  2002-10       Impact factor: 4.776

8.  Effects of weight loss on PLTP activity and HDL particle size.

Authors:  S Kaser; M Laimer; A Sandhofer; K Salzmann; C F Ebenbichler; J R Patsch
Journal:  Int J Obes Relat Metab Disord       Date:  2004-10

Review 9.  Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet.

Authors:  Samir S Deeb; Alberto Zambon; Molly C Carr; Amir F Ayyobi; John D Brunzell
Journal:  J Lipid Res       Date:  2003-03-16       Impact factor: 5.922

10.  Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA.

Authors:  X C Jiang; P Moulin; E Quinet; I J Goldberg; L K Yacoub; L B Agellon; D Compton; R Schnitzer-Polokoff; A R Tall
Journal:  J Biol Chem       Date:  1991-03-05       Impact factor: 5.157

View more
  5 in total

1.  Adiposity is associated with DNA methylation profile in adipose tissue.

Authors:  Golareh Agha; E Andres Houseman; Karl T Kelsey; Charles B Eaton; Stephen L Buka; Eric B Loucks
Journal:  Int J Epidemiol       Date:  2014-12-25       Impact factor: 7.196

2.  Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases plasma CETP and increases apolipoprotein AI levels without improving the cholesterol efflux properties of HDL.

Authors:  Yanan Wang; Marieke Snel; Jacqueline T Jonker; Sebastiaan Hammer; Hildo J Lamb; Albert de Roos; A Edo Meinders; Hanno Pijl; Johannes A Romijn; Johannes W A Smit; Ingrid M Jazet; Patrick C N Rensen
Journal:  Diabetes Care       Date:  2011-10-12       Impact factor: 19.112

3.  Hepatic triglyceride content does not affect circulating CETP: lessons from a liraglutide intervention trial and a population-based cohort.

Authors:  Huub J van Eyk; Lisanne L Blauw; Maurice B Bizino; Yanan Wang; Ko Willems van Dijk; Renée de Mutsert; Johannes W A Smit; Hildo J Lamb; Ingrid M Jazet; Patrick C N Rensen
Journal:  Sci Rep       Date:  2019-07-10       Impact factor: 4.379

Review 4.  Dyslipidemia in obesity: mechanisms and potential targets.

Authors:  Boudewijn Klop; Jan Willem F Elte; Manuel Castro Cabezas
Journal:  Nutrients       Date:  2013-04-12       Impact factor: 5.717

Review 5.  Mechanisms linking excess adiposity and carcinogenesis promotion.

Authors:  Ana I Pérez-Hernández; Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Gema Frühbeck
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-01       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.